home.social

#stoppkd — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #stoppkd, aggregated by home.social.

  1. 🚫 STOP PKD - Study investigates a new treatment option for people with the most common form of genetic kidney disease 🧬
    The study aims to investigate the efficacy and safety of a already approved medication in the treatment of autosomal dominant polycystic kidney disease (#ADPKD). The study is funded and supported by the German Research Foundation (DFG) and international partner institutions.

    ▶️ uni.koeln/3H4TX

    ▶️ stop-pkd.de/

    #uniköln #unikologne #STOPPKD

  2. 🚫 STOP PKD – Studie untersucht eine neue Behandlungsmöglichkeit für Menschen mit der häufigsten genetischen Nierenerkrankung 🧬
    Ziel der Studie ist es, die Wirksamkeit und Sicherheit eines bereits zugelassenen Medikaments bei der Behandlung von autosomal dominanter polyzystischer Nierenkrankheit #ADPKD zu untersuchen. Die Studie wird von der DFG gefördert und finanziert.

    ▶️ uni.koeln/95N3X

    ▶️ stop-pkd.de/
    #uniköln #unicologne #STOPPKD

  3. 🚨 Big news in ADPKD research!

    Two upcoming RCTs on SGLT2i, aiming to extend #SGLT2i benefits to #ADPKD:

    🇫🇷 #DAPAPKD, PI @dguerrot & @ecorneclegall: 🎯 Total kidney volume evolution over 2y
    🌍 #STOPPKD, PI @MuellerRom, R.Gansevoort, P.Scherrer: 🎯Chronic eGFR slope over 3y

    🤝 Pooled analysis of 820 patients planned!

  4. 🚨 Big news in ADPKD research!

    Two upcoming RCTs on SGLT2i, aiming to extend #SGLT2i benefits to #ADPKD:

    🇫🇷 #DAPAPKD, PI @dguerrot & @ecorneclegall: 🎯 Total kidney volume evolution over 2y
    🌍 #STOPPKD, PI @MuellerRom, R.Gansevoort, P.Scherrer: 🎯Chronic eGFR slope over 3y

    🤝 Pooled analysis of 820 patients planned!

  5. 🚨 Big news in ADPKD research!

    Two upcoming RCTs on SGLT2i, aiming to extend #SGLT2i benefits to #ADPKD:

    🇫🇷 #DAPAPKD, PI @dguerrot & @ecorneclegall: 🎯 Total kidney volume evolution over 2y
    🌍 #STOPPKD, PI @MuellerRom, R.Gansevoort, P.Scherrer: 🎯Chronic eGFR slope over 3y

    🤝 Pooled analysis of 820 patients planned!